Serum visfatin levels in patients with atopic dermatitis and cutaneous T-cell lymphoma

被引:12
作者
Suga, Hiraku [1 ]
Sugaya, Makoto [1 ]
Miyagaki, Tomomitsu [1 ]
Kawaguchi, Makiko [1 ]
Morimura, Sohshi [1 ]
Kai, Hiromichi [1 ]
Kagami, Shinji [1 ]
Ohmatsu, Hanako [1 ]
Fujita, Hideki [1 ]
Asano, Yoshihide [1 ]
Tada, Yayoi [1 ]
Kadono, Takafumi [1 ]
Sato, Shinichi [1 ]
机构
[1] Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, Tokyo 1138655, Japan
关键词
visfatin; atopic dermatitis; cutaneous T-cell lymphoma; mycosis fungoides; adipose tissue; COLONY-ENHANCING FACTOR; MYCOSIS-FUNGOIDES; RHEUMATOID-ARTHRITIS; ADIPOSE-TISSUE; MESSENGER-RNA; EXPRESSION; PSORIASIS; DISEASE; IL-22; INFLAMMATION;
D O I
10.1684/ejd.2013.2107
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Visfatin, a novel adipocytokine, is related with chronic inflammatory diseases, especially those characterized by T helper (Th)1-type immune responses. In this study, we examined serum visfatin levels in patients with atopic dermatitis (AD) or cutaneous T-cell lymphoma (CTCL), both of which are Th2-dominant diseases. Serum visfatin levels in patients with AD or advanced stage CTCL were significantly elevated compared to healthy controls. In CTCL patients, serum visfatin levels significantly decreased after treatment. Serum visfatin levels correlated with eosinophil counts in AD patients, whereas they correlated with the visual analogue scale itch scores and serum C-C motif ligand (CCL) 11 and CCL26 levels in CTCL patients. Visfatin expression by adipose tissue in lesional skin of AD and advanced stage CTCL was enhanced compared to that of healthy controls. These results suggest that visfatin may also be important in the development of Th2-dominant diseases as well as in Th1-type diseases.
引用
收藏
页码:629 / 635
页数:7
相关论文
共 44 条
[1]   Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin 10 mRNA [J].
Asadullah, K ;
Docke, WD ;
Haeussler, A ;
Sterry, W ;
Volk, HD .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1996, 107 (06) :833-837
[2]   Visfatin: a Potential Therapeutic Target for Rheumatoid Arthritis [J].
Bao, J. P. ;
Chen, W. P. ;
Wu, L. D. .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2009, 37 (06) :1655-1661
[3]   The genetics of psoriasis, psoriatic arthritis and atopic dermatitis [J].
Bowcock, AM ;
Cookson, WOCM .
HUMAN MOLECULAR GENETICS, 2004, 13 :R43-R55
[4]   Pre-B cell colony-enhancing Factor/Visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities [J].
Brentano, Fabia ;
Schorr, Olivier ;
Ospelt, Caroline ;
Stanczyk, Joanna ;
Gay, Renate E. ;
Gay, Steffen ;
Kyburz, Diego .
ARTHRITIS AND RHEUMATISM, 2007, 56 (09) :2829-2839
[5]   Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci [J].
Cookson, WOCM ;
Ubhi, B ;
Lawrence, R ;
Abecasis, GR ;
Walley, AJ ;
Cox, HE ;
Coleman, R ;
Leaves, NI ;
Trembath, RC ;
Moffatt, MF ;
Harper, JI .
NATURE GENETICS, 2001, 27 (04) :372-373
[6]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[7]   Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and Adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans [J].
Fain, JN ;
Madan, AK ;
Hiler, ML ;
Cheema, P ;
Bahouth, SW .
ENDOCRINOLOGY, 2004, 145 (05) :2273-2282
[8]   Leptin and the regulation of body weight in mammals [J].
Friedman, JM ;
Halaas, JL .
NATURE, 1998, 395 (6704) :763-770
[9]   Leptin, adiponectin, visfatin and retinol-binding protein-4-mediators of comorbidities in patients with psoriasis? [J].
Gerdes, Sascha ;
Osadtschy, Svetlana ;
Rostami-Yazdi, Martin ;
Buhles, Norbert ;
Weichenthal, Michael ;
Mrowietz, Ulrich .
EXPERIMENTAL DERMATOLOGY, 2012, 21 (01) :43-47
[10]   Medical progress - The pathogenesis of mycosis fungoides [J].
Girardi, M ;
Heald, PW ;
Wilson, LD .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1978-1988